by Team Small News | Aug 31, 2025 | Pharma, Piramal Pharma
Piramal Pharma Solutions and George Medicines have collaborated to develop a new drug for the treatment of hypertension, known as Widaplik. This development is a significant milestone in the pharmaceutical industry, as hypertension is a major health concern worldwide....
by Team Small News | Aug 29, 2025 | Pharma, Piramal Pharma
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO), has collaborated with George Medicines, a late-stage biopharma company, to develop WIDAPLIK, a new drug for the treatment of hypertension in adult patients. The US...
by Team Small News | Aug 27, 2025 | Pharma, Piramal Pharma
Piramal Pharma Limited (PPL) has released its FY2025 Sustainability Report, which highlights the company’s progress in integrating responsible practices across its operations worldwide. The report is themed “Innovating Responsibly, Growing...
by Team Small News | Aug 24, 2025 | Pharma, Piramal Pharma
Piramal Pharma has announced the opening of its new facility in the USA for the production of Oral Solid Dosage (OSD) forms. This move is expected to enhance the company’s capabilities in the global pharmaceutical market. The new facility, located in the United...
by Team Small News | Jul 24, 2025 | Pharma, Piramal Pharma
Piramal Pharma Limited (PPL) is expected to continue its upward trend in 2025, driven by breakthrough profits in the pharmaceutical sector. The company has been making significant strides in the industry, with a focus on innovation, research, and development. Here are...
by Team Small News | Jul 1, 2025 | Pharma, Piramal Pharma
Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organisation (CDMO), has announced a $90 million investment plan to expand two of its US facilities. The expansion is aimed at enhancing the company’s integrated offering,...